Trevogrumab (REGN-1033) — Research Compounds Library | RetatrutideCompare
Fully human monoclonal antibody against myostatin. Phase 2 trial in sarcopenic older adults (NCT01963598) showed lean-mass gains but no functional improvement.
Fully human monoclonal antibody against myostatin. Phase 2 trial in sarcopenic older adults (NCT01963598) showed lean-mass gains but no functional improvement.